| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/24/2011 | US20110044947 Methods of treating cardiac disorders |
| 02/24/2011 | US20110044935 Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 02/24/2011 | US20110044904 Crystal forms of 2--adenosine |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | US20110041857 Fibroblast derived stem cells |
| 02/24/2011 | DE202010015929U1 Medikamenten aufweisendes medizinisches Produkt zur Anwendung an den Blutgefäßen Drugs exhibiting a medical device for application to the blood vessels |
| 02/24/2011 | CA2769409A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287163A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/23/2011 | EP2287147A2 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 02/23/2011 | EP2286848A2 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286819A1 Pharmceuttical composition for treating cardio-cerebro vascular diseases and preparative method and kit thereof |
| 02/23/2011 | EP2286813A2 Use of naphthyridine derivatives as medicaments |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2286676A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 02/23/2011 | EP2286224A1 Method for improving cardiovascular risk profile of cox inhibitors |
| 02/23/2011 | EP2285817A2 Novel uses of d-mannopyranose derivatives activating angiogenesis |
| 02/23/2011 | EP2285394A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP2285371A2 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
| 02/23/2011 | EP2285358A1 Pulsatile release of valsartan |
| 02/23/2011 | EP1863570B1 A synergistically heat stable oil media having eicosa pentaenoic acid (epa) and docosa hexaenoic acid (dha) |
| 02/23/2011 | EP1812388B1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 02/23/2011 | EP1617218B1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR |
| 02/23/2011 | EP1556025B1 Compositions comprising vitamin k for preventing hypertension, left ventricular hypertrophy, congestive heart failure, myocardial infarction, stroke and coronary heart disease by preventing age-related stiffening of arteries |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | CN101981028A Substituted piperidines as renin inhibitors |
| 02/23/2011 | CN101981027A Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 02/23/2011 | CN101981026A Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |
| 02/23/2011 | CN101981008A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine II receptors |
| 02/23/2011 | CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/23/2011 | CN101981005A Atorvastatin-aliskiren |
| 02/23/2011 | CN101981004A Novel crystalline forms |
| 02/23/2011 | CN101980716A Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
| 02/23/2011 | CN101980701A Capsule for the prevention of cardiovascular diseases |
| 02/23/2011 | CN101979653A Peanut antihypertensive peptide and preparation method thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979402A Marine cyclic peptide compound and preparation method and use thereof |
| 02/23/2011 | CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101979077A Traditional Chinese medicine for treating heart cerebrovascular diseases |
| 02/23/2011 | CN101979044A Medicament for treating cerebral infarction and preparation method thereof |
| 02/23/2011 | CN101979043A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| 02/23/2011 | CN101979040A Medicament for treating central serous chorioretinopathy |
| 02/23/2011 | CN101979037A Medicament for treating diabetic complications and preparation method thereof |
| 02/23/2011 | CN101979031A Medicament for treating hemorrhoids and preparation method thereof |
| 02/23/2011 | CN101979030A Chinese medicinal ointment formula and preparation method and application thereof |
| 02/23/2011 | CN101979027A Method for detecting Jinze coronary disease capsules |
| 02/23/2011 | CN101979024A Medicament for treating heart and cerebrovascular diseases, intervertebral disc herniation, cervical spondylosis or hemiplegia |
| 02/23/2011 | CN101979021A Compound extractive with antioxidation activity |
| 02/23/2011 | CN101979020A Chinese medicinal preparation for treating high blood pressure |
| 02/23/2011 | CN101979012A Chinese medicament for treating diabetic retinopathy |
| 02/23/2011 | CN101979007A Traditional Chinese medicine for treating diabetic heart disease |
| 02/23/2011 | CN101978987A Application of herba rabdosiae rubescentis extract to preparation of medicament for treating and resisting cerebral ischemia |
| 02/23/2011 | CN101978980A Szechuan lovage rhizome total phthalide extract |
| 02/23/2011 | CN101978979A Method for preparing refined celery extract |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/23/2011 | CN101978950A Alpha-linolenic acid ester fat emulsion injection and preparation method thereof |
| 02/23/2011 | CN101978949A Gamma-linolenate fat emulsion intravenous injection and preparation method thereof |
| 02/23/2011 | CN101978910A Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
| 02/23/2011 | CN101632666B Drug composition used for treating high blood pressure |
| 02/23/2011 | CN101219120B Telmisartan dispersible tablet and method for preparing the same |
| 02/22/2011 | US7893291 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893100 carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates , compositions containing compounds |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893073 Heterocyclic derivatives |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7893048 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892582 Composition for oral administration containing capsaicinoids |
| 02/22/2011 | US7892574 Topical administration of oxazolidinones for transdermal delivery |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | CA2601515C Compounds having immunomodulator activity |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/22/2011 | CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/22/2011 | CA2185998C The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 02/17/2011 | WO2011019685A2 Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof |